📈 Perpetual Contract Listing | SKHYUSDT Now Live The SKHYUSDT Perpetual Contract is now available on BiFinance. Trade with greater flexibility and gain exposure to one of the world’s leading AI semiconductor companies. 📌 Trading Pair: SKHYUSDT 🕒 Trading Starts: July 20, 2026, 15:00 (UTC+8) Start trading now and seize new market opportunities! #BiFinance# #Perpetual# #USDT# #SKHynix# #CryptoTrading# #Futures# #AI# #Stocks#

“There’s a need for more responsible regulation of artificial intelligence,” says Fmr SEC Chairman @GaryGensler. “The existential risks are much harder to control.”

The best reason to stay is never running out of interesting problems to solve. That's how many people build their careers at JetBrains. Hear how Kirill Skrygan went from junior developer to CEO over 16 years.

Thrilled to announce the first SKYWARD IDE enrollment! Huge congratulations to Dr @NickMouawadMD & team at McLaren Bay Region Hospital in Bay City, MI on enrolling the first patient in the clinical program to evaluate the novel Shockwave SkyRunner Carotid IVL System for the treatment of calcified carotid arteries prior to stenting.  Read the Press Release:   CAUTION - Investigational device. Limited by US law to investigational use.

SKYWARD is off and running! Johnson & Johnson announced today the initiation of its SKYWARD IDE clinical program evaluating the novel Shockwave SkyRunner Carotid IVL System for the treatment of calcified carotid arteries prior to stenting. This clinical program is part of Johnson & Johnson’s plan to enhance treatment options for patients with calcified carotid artery disease, which accounts for up to one-third of all strokes. Read the Press Release: @JNJNews @JNJMedTech @NickMouawadMD CAUTION - Investigational device. Limited by US law to investigational use.